LuSeed’s ARC™ is a first-in-class, minimally invasive device for treating both Bifurcation and Sidewall brain aneurysms simply and safely. The device is designed for full compatibility with robotic systems.
It is our mission to provide a standard method of care, easily implemented by neuro radiologists at various experience levels, to improve both acute and long-term patient outcomes, mitigate potential complications, and optimize hospitals’ operational and financial burdens.
About LuSeed Vascular
LuSeed Vascular is a pioneering medical technology startup that focuses on advancing neurovascular innovation. Our primary commitment is to create and introduce groundbreaking devices that bring about significant improvements in the treatment outcomes of brain aneurysms.
Introducing LuSeed ARC™
"One-and-Done" Intrasaccular Device
The company’s flagship product, LuSeed ARC™, is designed to provide neuro interventional physicians with the means to enable better care for their patients by enabling an intuitive, safe delivery and implantation at the target aneurysm, thanks to its unique geometry and characteristics.
The device provides a first of its kind approach for both Bifurcation and Sidewall Aneurysms, as its positioning in the aneurysm is agnostic to the catheter tip location at the implantation site.
Moreover, the device does not require dual anticoagulants due to minimized protrusion to parent arteries, mitigating related complications and enhancing long term patient safety.
Broad indication for use
Designed for both bifurcation and sidewall aneurysms.
Five sizes only
Straightforward matching between the device and the aneurysm.
Acute Performance
Tailored for ruptured cases via high mesh density.
Easy to use
Agnostic to catheter tip location and entrance angle at the implantation site.
Optimized safety profile
Proximal marker protrusion-free geometry. No chronic usage of strong blood thinners required.
Short procedural time
Implantation within minutes, reducing Cath-lab use time.
LuSeed Vascular is an innovative MedTech start-up dedicated to the development of cutting-edge solutions for treating neurovascular diseases.
The company’s flagship product, LuSeed ARC™ , is the world’s first “One and Done” aneurysm treatment device tailor-made for both bifurcation and sidewall cases.
LuSeedARC™’s revolutionary braided mesh design enables a quick, easy delivery and positioning within the aneurysm from multiple angles, featuring a gradual, controlled, accurate deployment.
LuSeed ARC™ is designed to minimize protrusion to parent artery, mitigating the chronic need for high-risk Dual Antiplatelets.
